metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome
Indegene, a technology-led global healthcare solutions provider, and metaMe Health, a Prescription Digital Therapeutics (PDT) company and developer of Regulora, today announced a partnership to bring Regulora to market for the treatment of abdominal pain due to Irritable Bowel Syndrome (IBS). Through a multi-year partnership, Indegene will work with metaMe Health to use its flexible and capital-efficient commercial model to educate healthcare providers, patients, and payers about the benefits of this innovative treatment. Indegene’s unique Co-Commercialization model ensures that Regulora reaches the right patients while allowing metaMe to focus on its mission of developing innovative Prescription Digital Therapeutics.
#institution
#pdt